Corporate Social Responsibility Disclosure, Corporate Governance Disclosures, and Firm Value In Indonesia Chemical, Plastic, and Packaging Sub-Sector Companies

Firmansyah, Amrie; Husna, Mitsalina Choirun; Putri, Maritsa Agasta

doi:10.15294/aaj.v10i1.42102

Cited by 23 publications

(19 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In addition to this, the intense competition in business against current economic developments has led to the company's demands to continue to develop creativity and product innovation, improve performance within the company and expand its business to be more recognized by the public. High firm value can affect market response; investors will assume that the company has good operational performance and has made the business world only focus on making profits (Hardiyansah et al, 2021) (Kasim et al, 2022) (Nisa et al, 2021) (Firmansyah, et al, 2021) (Putri, et al, 2020).…”

Section: Introductionmentioning

confidence: 99%

Corporate Social Responsibility, Firm Value, and Profitability: Evidence from Pharmaceutical Companies in Indonesia and Malaysia

Hermawan

Sari²,

Biduri³

et al. 2023

J. Professional Business Review

View full text Add to dashboard Cite

Purpose: This study was conducted with the aim of testing the Effect of Corporate Social Responsibility (CSR) on Firm Value with Profitability as a Moderating Variable. Theoretical framework: Pharmaceutical companies are very closely related to the environment around the company. In the operational activities of companies that process 9 types of chemicals, they can potentially trigger the release of substances that can damage the surrounding environment, so that waste management is needed. This study explores the violation of corporate practice by linking the implementation of CSR. Design/methodology/approach: We use documentation technique as data collection and analysis of outer model and inner model as data analysis using smartPLS software. This research was conducted on Indonesian pharmaceutical companies listed on the Indonesia Stock Exchange for the 2016-2020 period and Malaysian pharmaceutical companies listed on the Malaysia Stock Exchange for the 2016-2020 period. By using purposive sampling method, 8 Indonesian pharmaceutical companies were selected from 10 companies, and 8 Malaysian pharmaceutical companies from 16 companies were selected as samples that met the requirements. Findings: Corporate Social Responsibility Affects the Value of Indonesian Pharmaceutical Companies. Corporate Social Responsibility Does Not Affect The Value of Malaysian Pharmaceutical Companies. Profitability is able to moderate the influence of Corporate Social Responsibility on the value of Indonesian and Malaysian pharmaceutical companies. Research, Practical & Social implications: Future studies may consider indicators of the influence of CSR on firm value with profitability as a moderating variable. Originality/value: Indonesian pharmaceutical companies show results that Corporate Social Responsibility (CSR) has an effect on firm value, Malaysian pharmaceutical companies show results that Corporate Social Responsibility (CSR) has no effect on firm value, Indonesian pharmaceutical companies show that profitability is able to moderate the influence of Corporate Social Responsibility (CSR) on firm value, Malaysian pharmaceutical companies show results that profitability is able to moderate the effect of Corporate Social Responsibility (CSR) on firm value.

show abstract

Section: Introductionmentioning

confidence: 99%

Corporate Social Responsibility, Firm Value, and Profitability: Evidence from Pharmaceutical Companies in Indonesia and Malaysia

Hermawan

Sari²,

Biduri³

et al. 2023

J. Professional Business Review

View full text Add to dashboard Cite

show abstract

“…Firm value shows the market response to assets managed by managers (Firmansyah, Setiawan, & Fathurahman, 2020). In addition, firm value shows the performance of managers who are responded to by investors in the capital market (Firmansyah et al, 2021;Ihsani et al, 2021). Managers are expected to run the company's business following the wishes of shareholders (Jensen & Meckling, 1976).…”

Section: Resultsmentioning

confidence: 99%

Profitability, Firm Value, Income Smoothing: The Moderating Role of Firm Growth

Chandra

Firmansyah

Trisnawati

2023

riset

View full text Add to dashboard Cite

This study examines the effect of profitability and firm value on income smoothing. In addition, this study examines the moderate effect of firm growth on the relationship between these variables. This study employs a sample of companies in the banking sector listed on the IDX. The number of samples in this study is 31 observations based on purposive sampling. Moreover, the hypothesis in this study was examined with multiple regression analysis for cross-section data. The results of this study suggest that profitability and firm value are not associated with income smoothing. Furthermore, firm growth cannot strengthen the negative relationship between profitability and income smoothing. Also, firm growth cannot strengthen the negative relationship between firm value and income smoothing.

show abstract

“…The criteria for the sample in this study based on purposive sampling are as follows: The dependent variable analyzed in this study was firm value. The proxy for firm value in this study was Tobin's Q, the same proxy employed by (Firmansyah et al, 2021b;Ihsani et al, 2021;Putri et al, 2020).…”

Section: Methodsmentioning

confidence: 99%

Investor response to the implementation of IFRS 9 in Indonesian banking companies

Firmansyah,

Kurniawati,

Miftah

et al. 2023

J. Akun. Audit. Ind.

View full text Add to dashboard Cite

This study examines the effect of allowance for impairment losses on firm value. Allowance for impairment losses on the company's financial assets in the context of implementing IFRS 9 in the form of PSAK 71 in Indonesia on a forward-looking basis is different from the implementation of previous accounting standards, which was on a backward-looking basis. Quantitative methods are employed in this study using secondary data from banking financial reports sourced from www.idx.co.id during the 2019-2021 period. In addition, this study also employs stock price data sourced from www.finance.yahoo.co.id. The main data in this study is data for 2020, which is the first year of application of PSAK 71. While data for 2019 is used to compare the year before the application of PSAK 71, and 2021 is used to compare the application of PSAK 71 in the second year. Data testing was performed using multiple linear regression analysis for cross-section data. This study concludes that the allowance for impairment losses positively affects firm value in the first year. The results of this test are relevant in the second year of the implementation of PSAK 71. Meanwhile, it shows that the allowance for impairment losses has no effect on firm value in the year before the implementation of PSAK 71. This research contributes to the literature on implementing new financial accounting standards in Indonesia related to investor response in the capital market.

show abstract

Corporate Social Responsibility Disclosure, Corporate Governance Disclosures, and Firm Value In Indonesia Chemical, Plastic, and Packaging Sub-Sector Companies

Cited by 23 publications

References 13 publications

Corporate Social Responsibility, Firm Value, and Profitability: Evidence from Pharmaceutical Companies in Indonesia and Malaysia

Corporate Social Responsibility, Firm Value, and Profitability: Evidence from Pharmaceutical Companies in Indonesia and Malaysia

Profitability, Firm Value, Income Smoothing: The Moderating Role of Firm Growth

Investor response to the implementation of IFRS 9 in Indonesian banking companies

Contact Info

Product

Resources

About